Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000074
Filing Date
2024-11-01
Accepted
2024-10-31 19:51:26
Documents
12
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 6-K a2024-11x01activitystateme.htm 6-K 20918
2 EX-99.1 exhibit991.htm EX-99.1 33771
3 exhibit991001.jpg GRAPHIC 225528
4 exhibit991002.jpg GRAPHIC 273888
5 exhibit991003.jpg GRAPHIC 268568
6 exhibit991004.jpg GRAPHIC 254397
7 exhibit991005.jpg GRAPHIC 120394
8 exhibit991006.jpg GRAPHIC 123079
9 exhibit991007.jpg GRAPHIC 177948
10 exhibit991008.jpg GRAPHIC 234063
11 exhibit991009.jpg GRAPHIC 215596
12 exhibit991010.jpg GRAPHIC 142661
  Complete submission text file 0001345099-24-000074.txt   2860840
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241416633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)